Leisure Capital Management Edwards Lifesciences Corp Transaction History

Leisure Capital Management

$234 Million
Q3 2024

A detailed history of Leisure Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Leisure Capital Management holds 8,234 shares of EW stock, worth $615,985. This represents 0.23% of its overall portfolio holdings.

Number of Shares

8,234

Previous 9,176 10.27%

Holding current value

$615,985

Previous $847,000 35.89%

% of portfolio

0.23%

Previous 0.39%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$59.7 - $93.78 $56,237 - $88,340	-942 Reduced 10.27%	8,234 $543,000
Q2 2024 Jul 26, 2024	BUY	$84.3 - $94.31 $22,761 - $25,463	270 Added 3.03%	9,176 $847,000
Q1 2024 May 06, 2024	SELL	$72.54 - $95.56 $41,783 - $55,042	-576 Reduced 6.07%	8,906 $851,000
Q3 2023 Oct 30, 2023	SELL	$69.28 - $93.38 $3,117 - $4,202	-45 Reduced 0.47%	9,482 $656,000
Q2 2023 Jul 27, 2023	SELL	$81.41 - $94.33 $64,558 - $74,803	-793 Reduced 7.68%	9,527 $898,000
Q4 2022 Jan 27, 2023	SELL	$68.3 - $87.44 $9,220 - $11,804	-135 Reduced 1.29%	10,320 $769,000
Q3 2022 Nov 01, 2022	BUY	$82.37 - $107.29 $3,624 - $4,720	44 Added 0.42%	10,455 $864,000
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $21,207 - $26,694	-208 Reduced 1.96%	10,411 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $63,822 - $78,408	600 Added 5.99%	10,619 $1.38 Million
Q2 2021 Aug 06, 2021	SELL	$83.84 - $104.76 $25,319 - $31,637	-302 Reduced 2.93%	10,019 $1.04 Million
Q3 2020 Oct 23, 2020	SELL	$67.19 - $87.44 $13,438 - $17,488	-200 Reduced 1.9%	10,321 $824,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $384,309 - $513,949	6,679 Added 173.84%	10,521 $727,000
Q1 2020 May 07, 2020	BUY	$52.41 - $81.0 $54,768 - $84,645	1,045 Added 37.36%	3,842 $725,000
Q4 2019 Jan 27, 2020	BUY	$71.7 - $82.09 $1,649 - $1,888	23 Added 0.83%	2,797 $653,000
Q3 2019 Nov 08, 2019	SELL	$61.55 - $75.43 $20,927 - $25,646	-340 Reduced 10.92%	2,774 $610,000
Q2 2019 Jul 10, 2019	SELL	$55.74 - $64.41 $10,813 - $12,495	-194 Reduced 5.86%	3,114 $575,000
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $13,983 - $18,702	-292 Reduced 8.11%	3,308 $633,000
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $19,167 - $23,516	-413 Reduced 10.29%	3,600 $551,000
Q3 2018 Nov 09, 2018	SELL	$45.7 - $58.03 $20,519 - $26,055	-449 Reduced 10.06%	4,013 $699,000
Q2 2018 Aug 02, 2018	SELL	$42.45 - $51.3 $131,977 - $159,491	-3,109 Reduced 41.06%	4,462 $650,000
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $85,797 - $109,467	-2,307 Reduced 23.35%	7,571 $1.06 Million
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $5,237 - $6,105	155 Added 1.59%	9,878 $1.11 Million
Q3 2017 Oct 24, 2017	BUY	$36.29 - $38.83 $352,847 - $377,544	9,723	9,723 $1.06 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Leisure Capital Management with notifications on news.

Account

Leisure Capital Management Edwards Lifesciences Corp Transaction History